| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Endocrinology (F.S., P.V., G.C., L.M., V.R., C.M., E.M., A.P.), Pharmaceutical Sciences (M.M.), and Plastic Surgery (G.G.), University of Pisa, 56124 Pisa, Italy; Endocrinology Unit, University of Pavia, Fondazione Salvatore Maugeri IRCCS (L.C.), Pavia, Italy; Department of Endocrinology, University of California (I.J.C.), Los Angeles, California 90095; and Section of Endocrinology, Boston University School of Medicine (J.D.S., L.E.B.), Boston, Massachusetts 02118
Address all correspondence and requests for reprints to: Dr. Ferruccio Santini, Department of Endocrinology, University of Pisa, Via Paradisa, 2, 56124 Pisa, Italy.
Creams containing thyroid hormone are commonly employed for cosmetic purposes. To verify whether T4 applied to the skin surface can enter the bloodstream either directly or as a metabolite, a cream containing L-T4 [3,5,3',5'-tetraiodothyronine (T4)] was self-applied by volunteers for 2 wk. No significant variations in urinary iodide, TSH, and serum (total and free) T4 and T3 concentrations were observed at any time relative to pretreatment values, whereas rT3 concentrations increased significantly 6 and 12 h after cream application. The increased rT3 concentration led us to investigate the presence of inner ring type III deiodinase (D3) activity in human skin. Using human surgical discard skin, we found that T4 can be carried across human epidermis in a liposome cream. Substantial inner ring deiodination was suggested by the fact that only 10% of transferred thyroid hormone remained as T4, and T3 was not detected. We then measured D3 activity in a surgical skin specimen. The Km for T3 was 1.74 nmol/liter, and the maximum velocity was 23.5 fmol/µg microsomal protein/h. In conclusion, our study indicates that normal human skin serves as a substantial, but incomplete, barrier to T4 passage. D3 plays an important role in augmenting T4 blockade by inactivating T4 to rT3.
Abbreviations: D3, Type III deiodinase; T2, 3,3'-diiodothyronine.
This article has been cited by other articles:
![]() |
M. Dentice, C. Luongo, S. Huang, R. Ambrosio, A. Elefante, D. Mirebeau-Prunier, A. M. Zavacki, G. Fenzi, M. Grachtchouk, M. Hutchin, et al. Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes PNAS, September 4, 2007; 104(36): 14466 - 14471. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Visser The elemental importance of sufficient iodine intake: a trace is not enough. Endocrinology, May 1, 2006; 147(5): 2095 - 2097. [Full Text] [PDF] |
||||
![]() |
J. Kohrle, F. Jakob, B. Contempre, and J. E. Dumont Selenium, the Thyroid, and the Endocrine System Endocr. Rev., December 1, 2005; 26(7): 944 - 984. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Santini, A. Pinchera, A. Marsili, G. Ceccarini, M. G. Castagna, R. Valeriano, M. Giannetti, D. Taddei, R. Centoni, G. Scartabelli, et al. Lean Body Mass Is a Major Determinant of Levothyroxine Dosage in the Treatment of Thyroid Diseases J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 124 - 127. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |